Fulcrum Equity Management Pfizer Inc Transaction History

Fulcrum Equity Management

$82 Million
Q1 2024

A detailed history of Fulcrum Equity Management transactions in Pfizer Inc stock. As of the latest transaction made, Fulcrum Equity Management holds 16,227 shares of PFE stock, worth $449,812. This represents 0.55% of its overall portfolio holdings.

Number of Shares

16,227

Previous 14,704 10.36%

Holding current value

$449,812

Previous $423,000 6.38%

% of portfolio

0.55%

Previous 0.53%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $39,430 - $45,278	1,523 Added 10.36%	16,227 $450,000
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $64,906 - $84,306	-2,484 Reduced 14.45%	14,704 $423,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $176,591 - $206,417	5,503 Added 47.09%	17,188 $570,000
Q2 2023 Jul 07, 2023	SELL	$36.12 - $41.79 $73,143 - $84,624	-2,025 Reduced 14.77%	11,685 $428,000
Q1 2023 Apr 06, 2023	BUY	$39.39 - $51.28 $117,421 - $152,865	2,981 Added 27.78%	13,710 $559,000

Q4 2022 Jul 07, 2023	SELL	$41.75 - $54.5 $39,913 - $52,102	-956 Reduced 8.18%	10,729 $549,000
Q4 2022 Jan 10, 2023	BUY	$41.75 - $54.5 $3,507 - $4,578	84 Added 0.79%	10,729 $0
Q3 2022 Oct 11, 2022	BUY	$43.76 - $53.42 $4,025 - $4,914	92 Added 0.87%	10,645 $466,000
Q2 2022 Jul 18, 2022	BUY	$46.53 - $55.17 $2,652 - $3,144	57 Added 0.54%	10,553 $553,000
Q1 2022 Apr 15, 2022	SELL	$45.75 - $56.69 $17,430 - $21,598	-381 Reduced 3.5%	10,496 $543,000
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $18,511 - $27,440	-448 Reduced 3.96%	10,877 $642,000
Q3 2021 Jan 25, 2022	BUY	$39.25 - $50.42 $82,621 - $106,134	2,105 Added 22.83%	11,325 $487,000
Q2 2021 Jul 15, 2021	BUY	$35.91 - $40.68 $76,811 - $87,014	2,139 Added 30.21%	9,220 $361,000
Q1 2021 Apr 05, 2021	SELL	$33.49 - $37.77 $151,073 - $170,380	-4,511 Reduced 38.91%	7,081 $257,000
Q4 2020 Feb 22, 2021	SELL	$33.47 - $42.56 $18,006 - $22,897	-538 Reduced 4.44%	11,592 $427,000
Q3 2020 Oct 27, 2020	SELL	$31.75 - $37.25 $162,337 - $190,459	-5,113 Reduced 29.65%	12,130 $445,000
Q2 2020 Aug 17, 2020	BUY	$30.12 - $36.54 $73,613 - $89,303	2,444 Added 16.51%	17,243 $564,000
Q1 2020 Apr 01, 2020	SELL	$27.03 - $38.62 $40,274 - $57,543	-1,490 Reduced 9.15%	14,799 $483,000
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $17,052 - $19,352	-518 Reduced 3.08%	16,289 $638,000
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $6,173 - $8,004	190 Added 1.14%	16,807 $604,000
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $107,352 - $120,532	2,903 Added 21.17%	16,617 $604,000
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $7,612 - $8,363	-203 Reduced 1.46%	13,714 $582,000
Q4 2018 Mar 05, 2019	BUY	$38.47 - $43.86 $535,386 - $610,399	13,917 New	13,917 $607,000

Others Institutions Holding PFE

# of Institutions

3,164

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Equity Management, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Equity Management with notifications on news.

Account

Fulcrum Equity Management Pfizer Inc Transaction History